Zenas BioPharma, Inc. (ZBIO)
29.43
+1.17
(+4.14%)
USD |
NASDAQ |
Nov 09, 14:28
Zenas BioPharma Price : 29.43 for Nov. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 06, 2026 | 26.21 | 28.44 | 25.83 | 28.26 | 543969.0 |
| Nov 05, 2026 | 28.10 | 28.49 | 25.79 | 25.93 | 825642.0 |
| Nov 04, 2026 | 29.27 | 29.91 | 28.01 | 28.46 | 800741.0 |
| Nov 03, 2026 | 27.85 | 29.05 | 27.84 | 28.38 | 572844.0 |
| Nov 02, 2026 | 28.47 | 29.09 | 27.14 | 27.62 | 408284.0 |
| Oct 30, 2026 | 28.35 | 29.11 | 27.91 | 28.39 | 358070.0 |
| Oct 29, 2026 | 29.08 | 29.61 | 28.37 | 28.76 | 373026.0 |
| Oct 28, 2026 | 27.10 | 29.07 | 27.03 | 28.77 | 394278.0 |
| Oct 27, 2026 | 27.09 | 28.23 | 26.72 | 27.30 | 581012.0 |
| Oct 26, 2026 | 27.18 | 28.18 | 26.68 | 27.24 | 371648.0 |
| Oct 23, 2026 | 28.00 | 28.33 | 26.73 | 26.87 | 377550.0 |
| Oct 22, 2026 | 27.95 | 28.83 | 27.51 | 28.23 | 406015.0 |
| Oct 21, 2026 | 28.47 | 29.44 | 27.90 | 28.08 | 483990.0 |
| Oct 20, 2026 | 26.38 | 29.70 | 26.38 | 28.18 | 549017.0 |
| Oct 19, 2026 | 25.08 | 27.55 | 25.08 | 26.71 | 696545.0 |
| Oct 16, 2026 | 25.36 | 25.96 | 24.51 | 24.84 | 661797.0 |
| Oct 15, 2026 | 24.96 | 25.94 | 24.25 | 25.40 | 471938.0 |
| Oct 14, 2026 | 24.82 | 26.49 | 24.39 | 24.86 | 425053.0 |
| Oct 13, 2026 | 26.11 | 27.00 | 25.04 | 25.16 | 519662.0 |
| Oct 12, 2026 | 26.93 | 27.49 | 26.30 | 26.40 | 602493.0 |
| Oct 09, 2026 | 26.18 | 27.64 | 26.18 | 27.26 | 429819.0 |
| Oct 08, 2026 | 27.98 | 27.98 | 25.51 | 26.24 | 557492.0 |
| Oct 07, 2026 | 26.89 | 28.86 | 26.78 | 28.18 | 509230.0 |
| Oct 06, 2026 | 27.87 | 28.14 | 26.28 | 26.94 | 357596.0 |
| Oct 05, 2026 | 28.47 | 29.06 | 27.77 | 27.83 | 1.132M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.40 |
| Alnylam Pharmaceuticals, Inc. | 156.70 |
| Anika Therapeutics, Inc. | 14.58 |
| Savara, Inc. | 4.98 |
| Vericel Corp. | 58.23 |
Price Related Metrics
| PS Ratio | 154.76 |
| PEG Ratio | -0.0241 |
| Price to Book Value | 9.398 |
| Earnings Yield | -34.12% |
| Market Cap | 1.864B |
| PEGY Ratio | -0.0241 |